The use of IRAP is an effective intra-articular treatment for joint disease. The IRAP system is designed to stimulate the horse's own white blood cells to produce anti-inflammatory mediators and enzymes. These mediators and enzymes reduce inflammation caused by degenerative joint disease. Initially, the patient's blood sample is collected and brought to our clinic for incubation (24 hours) and processing.). After processing, the IRAP is ready to be used. However, additional doses may be stored at our clinic for up to one year. The injection process is typically done under sedation at the patient's field location. When injected into a joint, the protein-rich serum stimulates a regenerative response from cartilage cells, through a process of cell division and increased cell recruitment. This gives IRAP a disease-modifying component and an anti-inflammatory component. The serum also contains cytokines that act to reduce inflammation within the joint. In addition, there are other anti-inflammatory proteins produced during the incubation process that work synergistically with the cytokines to further reduce the inflammation within the diseased joint.
Type: General Care
Availability:
ID: 5785
